Disclosure Intervention to Reduce Social Isolation and Facilitate Recovery Among People in Treatment for Opioid Use Disorder
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Opioid Use Disorder
- Sponsor
- University of Delaware
- Enrollment
- 480
- Locations
- 1
- Primary Endpoint
- Illicit opioid use
- Status
- Recruiting
- Last Updated
- 9 months ago
Overview
Brief Summary
The goal of this clinical trial is to test a disclosure intervention among people in treatment for opioid use disorder. The main question it aims to answer is whether people who receive a disclosure intervention have better treatment- and recovery-related outcomes one year after receiving the intervention. Participants will complete a brief disclosure intervention designed to help them (1) make key disclosures related to disclosure and (2) build skills to disclose. Researchers will compare results to participants in a waitlist comparator condition, who receive the intervention at the end of the study.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Client of Brandywine Counseling \& Community Services
- •Receiving opioid use disorder treatment at Brandywine Counseling \& Community Services
- •Considering disclosing one's opioid use disorder history and/or treatment to someone new
Exclusion Criteria
- •Diagnosis of schizophrenia
- •Participation in pilot study of intervention
Outcomes
Primary Outcomes
Illicit opioid use
Time Frame: 1 year
Percentages of drug screens that are positive for illicit opioid use
Retention in treatment
Time Frame: 1 year
Whether participants are retained in treatment 1 year after baseline
Secondary Outcomes
- Recovery capital score(1 year)
- Quality of life score(1 year)